Paper Details

  1. Home
  2. Paper Details

3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.

Author: CamarasaJordi, CarbóMarcel Lí, EscubedoElena, Espinosa-VelascoMaría, López-ArnauRaúl, Nadal-GratacósNúria, PubillDavid, PuigsesllosesPol, UrquizuEdurne

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Psychoactive substances are being explored as alternative treatments for psychiatric disorders, particularly those that don't respond well to conventional medicines. While these substances have a history of recreational use, their potential benefits in treating conditions like post-traumatic stress disorder and treatment-resistant depression are being studied in controlled settings. Some promising substances include MDMA, ketamine, psilocybin, and LSD. New psychoactive substances (NPS) are also being investigated, offering a potential new approach to treating mental illnesses.
Paper Details　
Original Abstract of the Article :
The utility of classical drugs used to treat psychiatric disorders (e.g., antidepressants, anxiolytics) is often limited by issues of lack of efficacy, delayed onset of action or side effects. Psychoactive substances have a long history of being used as tools to alter consciousness and as a gateway ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574023/

データ提供：米国国立医学図書館（NLM）

From Recreational to Therapeutic: The Potential of Psychedelic Drugs in Psychiatry

Psychiatric disorders, like a desert mirage, can be elusive and challenging to treat. This study explores the potential of psychoactive substances, such as MDMA, ketamine, psilocybin, and LSD, for treating mental illnesses, like a camel seeking a hidden oasis in the vast desert of mental health.

A New Frontier in Psychiatry: Exploring the Therapeutic Potential of Psychedelic Drugs

The study highlights the growing interest in the therapeutic potential of psychedelic drugs, like a desert traveler discovering a new path leading to a hidden treasure. It discusses the use of these substances in controlled settings, often in combination with psychotherapy, for conditions like post-traumatic stress disorder and treatment-resistant depression. The study acknowledges the complex history and potential risks associated with these drugs, but emphasizes the need for further research to fully understand their therapeutic potential.

Expanding the Therapeutic Landscape: A Journey Towards New Solutions

This study suggests that psychedelic drugs, like a camel discovering a new source of water in a barren desert, could offer a valuable addition to the current therapeutic landscape for mental illnesses. The research highlights the need for responsible exploration and careful investigation to determine their potential benefits and risks, like a camel approaching a new oasis with caution and a sense of adventure.

Dr.Camel's Conclusion

This study explores the fascinating and complex world of psychedelic drugs, like a camel navigating a landscape of both beauty and danger. It provides a valuable perspective on the potential of these substances for treating mental illnesses, offering a glimmer of hope for those who are struggling to find effective therapies. It's a reminder that scientific research, like a camel's journey through the desert, can lead us to unexpected discoveries and open new paths towards a healthier future.
Date :
  1. Date Completed n.d.
  2. Date Revised 2022-10-21
Further Info :

Pubmed ID

36262632

DOI: Digital Object Identifier

PMC9574023

Related Literature

Article Analysis
・Side Effects of methamphetamine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.